| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies REW Hancock, HG Sahl Nature biotechnology 24 (12), 1551-1557, 2006 | 4325 | 2006 |
| A new antibiotic kills pathogens without detectable resistance. LK Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP ... Nature 517 (7535), 455-459., 2015 | 2569 | 2015 |
| Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature PG Arnison, MJ Bibb, G Bierbaum, AA Bowers, TS Bugni, G Bulaj, ... Natural product reports 30 (1), 108-160, 2013 | 1795 | 2013 |
| The co-evolution of host cationic antimicrobial peptides and microbial resistance A Peschel, HG Sahl Nature Reviews Microbiology 4 (7), 529-536, 2006 | 1157 | 2006 |
| Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic E Breukink, I Wiedemann, C Kraaij, OP Kuipers, HG Sahl, B De Kruijff Science 286 (5448), 2361-2364, 1999 | 1006 | 1999 |
| Insights into the mode of action of chitosan as an antibacterial compound D Raafat, K Von Bargen, A Haas, HG Sahl Applied and environmental microbiology 74 (12), 3764-3773, 2008 | 966 | 2008 |
| Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity I Wiedemann, E Breukink, C van Kraaij, OP Kuipers, G Bierbaum, ... Journal of Biological Chemistry 276 (3), 1772-1779, 2001 | 908 | 2001 |
| Chitosan and its antimicrobial potential–a critical literature survey D Raafat, HG Sahl Microbial biotechnology 2 (2), 186-201, 2009 | 843 | 2009 |
| Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria HG Sahl, G Bierbaum Annual Reviews in Microbiology 52 (1), 41-79, 1998 | 638 | 1998 |
| Lantibiotics: mode of action, biosynthesis and bioengineering G Bierbaum, HG Sahl Current pharmaceutical biotechnology 10 (1), 2-18, 2009 | 613 | 2009 |
| Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates G Marklein, M Josten, U Klanke, E Muller, R Horre, T Maier, T Wenzel, ... Journal of clinical microbiology 47 (9), 2912-2917, 2009 | 544 | 2009 |
| Dysregulation of bacterial proteolytic machinery by a new class of antibiotics H Brötz-Oesterhelt, D Beyer, HP Kroll, R Endermann, C Ladel, ... Nature medicine 11 (10), 1082-1087, 2005 | 533 | 2005 |
| Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II T Schneider, T Kruse, R Wimmer, I Wiedemann, V Sass, U Pag, A Jansen, ... Science 328 (5982), 1168-1172, 2010 | 530 | 2010 |
| Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics H Brötz, M Josten, I Wiedemann, U Schneider, F Götz, G Bierbaum, ... Molecular microbiology 30 (2), 317-327, 1998 | 508 | 1998 |
| The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II H Brötz, G Bierbaum, K Leopold, PE Reynolds, HG Sahl Antimicrobial agents and chemotherapy 42 (1), 154-160, 1998 | 490 | 1998 |
| Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles E Ruhr, HG Sahl Antimicrobial agents and chemotherapy 27 (5), 841-845, 1985 | 480 | 1985 |
| Biosynthesis and biological activities of lantibiotics with unique post‐translational modifications HG Sahl, RW Jack, G Bierbaum European Journal of Biochemistry 230 (3), 827-853, 1995 | 473 | 1995 |
| Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria Y Héchard, HG Sahl Biochimie 84 (5-6), 545-557, 2002 | 436 | 2002 |
| Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall AS Bayer, T Schneider, HG Sahl Annals of the New York Academy of Sciences 1277 (1), 139-158, 2013 | 373 | 2013 |
| Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid … T Jones, MR Yeaman, G Sakoulas, SJ Yang, RA Proctor, HG Sahl, ... Antimicrobial agents and chemotherapy 52 (1), 269-278, 2008 | 355 | 2008 |
Heike Brötz-OesterheltProfessor for Microbiology, IMIT, University of TuebingenVerified email at uni-tuebingen.de
